T Cells in Helminth Infection: The

Total Page:16

File Type:pdf, Size:1020Kb

T Cells in Helminth Infection: The Review T cells in helminth infection: the regulators and the regulated Matthew D. Taylor, Nienke van der Werf and Rick M. Maizels Institute of Immunology and Infection Research, University of Edinburgh, Ashworth Laboratories, West Mains Road, Edinburgh EH9 3JT, UK Helminth parasites survive through a combination of par- (mostly expressing CD25), B cells and macrophages [6]. asite longevity, repeated re-infection and selective im- In addition, suppressive cytokines such as TGF-b and IL- mune suppression to prevent protective Th2 responses. 10, produced by diverse hematopoietic and non-hemato- To counteract helminth-induced immunosuppression, poietic cells are integral to immunoregulatory pathways and to induce long-term immunological memory, under- [7,8]. Although the complexity of regulatory cell types + + + standing of the multiple regulatory pathways within the T continues to be charted, CD4 CD25 Foxp3 Tregs remain cell compartment is needed. Extrinsic inhibition by regu- the most prominent population of immunoregulatory latory T cells is a key element of Th2 suppression. cells operating during helminth infections described to In addition, Th2 cells in chronic regulatory environments date. become functionally impaired, indicating cell-intrinsic Immunoregulation in helminth infection was first rec- regulation, which compromises protective Th2 memory. ognized in early human studies, because peripheral T cells We discuss these pathways and consider the potential in infected patients were frequently unresponsive to para- for reversing unresponsiveness through stimulatory site antigens and responses to bystander antigens (includ- signals or replacement by new responder populations. ing allergens and vaccines) were also reduced [9]. In Future vaccine or therapeutic strategies should aim to addition, antibody isotypes were distorted, with exception- minimize extrinsic regulatory effects and simultaneously ally high concentrations of IgG4 that is, in part, attribut- negate Th2 anergy to drive effector responses into a long- able to Treg activity [10]. TGF-b and IL-10-producing term functionally competent state. Tregs were then cloned from Onchocerca volvulus-infected patients [11], and higher Foxp3 expression was found in Helminths and the immune system peripheral blood T cells from cases of active lymphatic Helminth parasites establish and assimilate themselves filariasis and schistosomiasis [12–14]. This field research for long periods in the host and immunoregulation plays a provides a firm basis for investigating the role of Tregs in key role in their survival strategy [1]. Helminths are large, experimental infection models. multicellular pathogens and the immune system has evolved a suite of specialized effector mechanisms cen- + Helminth infections drive Foxp3 Treg responses tered around the Th2 pathway (Box 1) to degrade and In murine infection models, helminth infections elicit both eliminate them [2]. However, parasites have countered by + ‘natural’ and ‘adaptive’ Foxp3 Treg cell responses, which engaging directly with host signals that regulate and tune + dampen Th2 immunity. Foxp3 Treg numbers can expand effector pathways [3,4]. When the host response does rapidly following filarial and gastrointestinal nematode overcome parasite resistance, it is often at the cost of infections, with significant increases within 3–7 days incurring pathology [5]; perhaps for this reason immunity + + [15–20]. Moreover, CD4 Foxp3 cells respond to infection is restrained by parasite immunomodulators and by en- + more rapidly than CD4 Foxp3À effector T (Teff) cells, in- dogenous regulatory mechanisms. We review recent data creasing their frequency and biasing the initial response showing how regulatory networks develop through a com- + + towards a regulatory phenotype [16,17,21]. Early Foxp3 bination of extrinsic inhibition by Foxp3 regulatory T Treg responses are not merely homeostatic as induction cells (Tregs) and intrinsic regulation of Th2 effector cell requires live (rather than heat-killed) parasites [16], where- populations, through processes such as anergy, exhaus- as other infections, such as Toxoplasma gondii, cause a tion or adaptive tolerance. The impact of these regulatory + precipitous loss of Foxp3 Tregs [22]. Conversely, drug- networks on the development of Th2 memory, and the + induced clearance of helminths reduces Foxp3 Treg num- potential for reversing unresponsiveness through stimu- bers and improves responses to bystander antigens [23,24]. latory signals and/or replenishing effector populations, In parallel with quantitative expansion of Tregs, hel- are discussed. minths can also induce elevated expression of CD103 and + other activation markers on Foxp3 Tregs [15–17,25–27], The regulators: regulatory T cells in helminth infection which exert a more potent suppressive function [15,18]. Multiple types of immunosuppressive cells operate in the Thus, the regulatory capacity of the Treg subset in vivo + + + immune system, including CD4 Foxp3 regulatory T cells may be reflected not simply by the proportion of Foxp3 cells, but more accurately by expression of activation Corresponding authors: Taylor, M.D. ([email protected]); Maizels, R.M. ([email protected]). markers. 1471-4906/$ – see front matter ß 2012 Published by Elsevier Ltd. doi:10.1016/j.it.2012.01.001 Trends in Immunology, April 2012, Vol. 33, No. 4 181 Review Trends in Immunology April 2012, Vol. 33, No. 4 Box 1. Mechanisms of Th2 immunity to helminths Two main arenas are considered: in the gastrointestinal tract, of the tissues, skin-penetrating helminth larvae can be intercepted by mucosal immunity involves both innate and adaptive populations. IL-5-dependent eosinophils; bloodstream microfilariae are cleared by Innate effector mechanisms include goblet cells, which increase IgM-dependent antibody mechanisms; and in internal organs multi- mucin production, switch mucin types (e.g. to MUC5AC) and release ple (and potentially redundant) populations or granulocytes and the effector protein resistin-like molecule-b (RELM-a); mast cells and macrophages are guided by chemokines, cytokines and antibodies to alternatively activated macrophages, each driven by type 2 cytokines attack helminths through pre-formed mediators and reactive meta- from Th2 and innate lymphoid (‘nuocyte’) cells. In the different setting bolites. Mucosal Tissue Epidermis (IgE) Skin IL-33, TSLP IL-5 IL-13 IL-25, IL-33 Eosinophils Nuocyte FcR Mast Cells Th2 IgM MCP proteases IL-4R cell Bloodstream open tight junctions IL-13 allowing fluid egress IgG neutralization IL-4 (e.g. blocking Tissue immunomodulation) Epithelial cell turnover (e.g. lung) goblet cell hyperplasia Macrophage-rich “type 2” IgG opsonization granuloma in intestinal wall B cell Arginase, RELM-α, YM- 1 Granule contents Mucins (MUC5AC) RELMβ IgA, IgG1 inhibit motility and CXCR2 FcεR FcεR reduce feeding fitness Neutrophils Eosinophils Basophils Macrophages IL-5 IL-3 IL-4 Reduced viability, lower Th2 IL-13 transmission, early expulsion cell + Foxp3 Tregs in resistance to helminth infections Likewise, depletion of Tregs in Foxp3-DTR Strongyloides + Although the main role of Foxp3 Tregs is to maintain ratti-infected mice increases host resistance if performed tolerance and control excessive inflammatory responses, within the first 4 days [20]. In infections with both filarial the trade-off is inhibited protective immune responses, Litomosoides sigmodontis and geohelminth S. ratti para- a property exploited by helminth parasites to immuno- sites, increased resistance appears to act on the adult, suppress their host. Experimentally, two imperfect rather than larval, stage [17,20] and long-term Th2 en- + approaches are available to test whether Foxp3 Tregs hancement outlasts the direct effects of depletion [17]. In + are required for parasite survival. Anti-CD25 antibodies these settings, Foxp3 Tregs inhibit the priming of Th2 + + can be used for long-term depletion of CD25 Foxp3 responses and limit the quantity or functional quality of Tregs, with the caveat that this also depletes activated the effector T cell pool available at later times. + Teffs while sparing CD25ÀFoxp3 Tregs. Alternatively, a Reflecting the diversity of helminth life histories, it is diphtheria toxin receptor (DTR) transgene expressed not surprising that each species displays a unique interac- + specifically by Foxp3 cells [28,29] permits short-term tion with Tregs. For example, in Trichuris muris infection, + depletion of Foxp3 Tregs, but this approach is less early intervention with anti-GITR, but not anti-CD25, applicable to chronic infection models. antibodies is most effective at reducing worm loads [31]. + The rapid rise in Foxp3 Treg numbers in infection Anti-CD25 depletion is reported to be ineffective at boost- suggests that a suppressive response pre-empts establish- ing immunity to other helminths, including Schistosoma ment of Th2 immunity. Accordingly, antibody-mediated mansoni [32,33] and Trichinella spiralis [34]. Experiments + depletion of CD25 Treg cells prior to infection increases with Foxp3-DTR mice will be interesting in this regard Th2 responses to, and killing of, filarial parasites [17,30]. and, although Foxp3-depleted mice are not more resistant 182 Review Trends in Immunology April 2012, Vol. 33, No. 4 + to the gastrointestinal nematode Heligmosomoides poly- of helminth immunity in humans [43–45] and with Foxp3 + gyrus in the first 14 days of infection [19], a longer time may Tregs in other settings, helminth-induced Foxp3 Tregs be required
Recommended publications
  • The TNF-Family Cytokine TL1A Drives IL-13-Dependent Small Intestinal Inflammation
    ARTICLES nature publishing group See ARTICLE page 186 The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation F M e y l a n 1 , 6 , Y - J S o n g 1 , 6 , I F u s s 2 , S V i l l a r r e a l 1 , E K a h l e 1 , I - J M a l m 1 , K A c h a r y a 1 , H L R a m o s 3 , L L o 4 , M M M e n t i n k - K a n e 5 , T A W y n n 5 , T - S M i g o n e 4 , W S t r o b e r 2 a n d R M S i e g e l 1 The tumor necrosis factor (TNF)-family cytokine TL1A (TNFSF15) costimulates T cells through its receptor DR3 (TNFRSF25) and is required for autoimmune pathology driven by diverse T-cell subsets. TL1A has been linked to human inflammatory bowel disease (IBD), but its pathogenic role is not known. We generated transgenic mice that constitutively express TL1A in T cells or dendritic cells. These mice spontaneously develop IL-13-dependent inflammatory small bowel pathology that strikingly resembles the intestinal response to nematode infections. These changes were dependent on the presence of a polyclonal T-cell receptor (TCR) repertoire, suggesting that they are driven by components in the intestinal flora. Forkhead box P3 (FoxP3)-positive regulatory T cells (Tregs) were present in increased numbers despite the fact that TL1A suppresses the generation of inducible Tregs.
    [Show full text]
  • ILC2 Activation by Protozoan Commensal Microbes
    International Journal of Molecular Sciences Review ILC2 Activation by Protozoan Commensal Microbes Kyle Burrows 1 , Louis Ngai 1 , Flora Wong 1,2, David Won 1 and Arthur Mortha 1,* 1 University of Toronto, Department of Immunology, Toronto, ON M5S 1A8, Canada; [email protected] (K.B.) [email protected] (L.N.); fl[email protected] (F.W.); [email protected] (D.W.) 2 Ranomics, Inc. Toronto, ON M5G 1X5, Canada * Correspondence: [email protected] Received: 3 September 2019; Accepted: 27 September 2019; Published: 30 September 2019 Abstract: Group 2 innate lymphoid cells (ILC2s) are a member of the ILC family and are involved in protective and pathogenic type 2 responses. Recent research has highlighted their involvement in modulating tissue and immune homeostasis during health and disease and has uncovered critical signaling circuits. While interactions of ILC2s with the bacterial microbiome are rather sparse, other microbial members of our microbiome, including helminths and protozoans, reveal new and exciting mechanisms of tissue regulation by ILC2s. Here we summarize the current field on ILC2 activation by the tissue and immune environment and highlight particularly new intriguing pathways of ILC2 regulation by protozoan commensals in the intestinal tract. Keywords: ILC2; protozoa; Trichomonas; Tritrichomonas musculis; mucosal immunity; taste receptors; succinate; intestinal immunity; type 2 immunity; commensals 1. The ILC Lineage 1.1. The Family of Innate Lymphoid Cells Research over the last decade has redirected focus away from classical immune cell interactions within lymphoid tissues towards immunity within non-lymphoid tissues. Within these tissues, immune interactions involve local adaptation and rapid responses by tissue-resident immune cells.
    [Show full text]
  • Lymphopenia-Induced Proliferation Lymphocytes During and After
    The Journal of Immunology Effects of Increasing IL-7 Availability on Lymphocytes during and after Lymphopenia-Induced Proliferation1 Nabil Bosco,* Fabien Agene`s,* and Rhodri Ceredig2† IL-7 is critically involved in regulating peripheral T cell homeostasis. To investigate the role of IL-7 on lymphopenia-induced proliferation of polyclonal lymphocytes, we have transferred CFSE-labeled cells into a novel T-lymphopenic, IL-7-transgenic mouse line. Results obtained indicate that T and B cells do not respond in the same way to IL-7-homeostatic signals. Overex- pression of IL-7 enhances proliferation of both CD4؉ and CD8؉ T cells but with distinctly temporal effects. Expansion of naturally arising CD4؉-regulatory T cells was like that of conventional CD4؉ T cells. IL-7 had no effect on B cell proliferation. By immunohistology, transferred T cells homed to T cell areas of spleen lymphoid follicles. Increasing IL-7 availability enhanced T cell recovery by promoting cell proliferation and reducing apoptosis during early stages of lymphopenia-induced proliferation. Taken together, these results provide new insights into the pleiotropic effects of IL-7 on lymphopenia-induced T cell proliferation. The Journal of Immunology, 2005, 175: 162–170. espite declining thymic output with age, the peripheral T either IL-7-deficient or wild-type mice treated with anti-IL-7 or cell pool of an adult animal remains remarkably stable anti-IL-7R␣ mAb show that perturbation of IL-7 signals prevents D (1, 2). How the T cell pool is maintained remains a cen- the expansion of transferred T cells (1, 10).
    [Show full text]
  • Innate Lymphocytes—Lineage, Localization and Timing of Differentiation
    Cellular & Molecular Immunology www.nature.com/cmi REVIEW ARTICLE Innate lymphocytes—lineage, localization and timing of differentiation Emily R. Kansler1,2 and Ming O. Li1 Innate lymphocytes are a diverse population of cells that carry out specialized functions in steady-state homeostasis and during immune challenge. While circulating cytotoxic natural killer (NK) cells have been studied for decades, tissue-resident innate lymphoid cells (ILCs) have only been characterized and studied over the past few years. As ILCs have been largely viewed in the context of helper T-cell biology, models of ILC lineage and function have been founded within this perspective. Notably, tissue- resident innate lymphocytes with cytotoxic potential have been described in an array of tissues, yet whether they are derived from the NK or ILC lineage is only beginning to be elucidated. In this review, we aim to shed light on the identities of innate lymphocytes through the lenses of cell lineage, localization, and timing of differentiation. Cellular & Molecular Immunology (2019) 16:627–633; https://doi.org/10.1038/s41423-019-0211-7 INTRODUCTION memory T cells have been described.3 Central memory T (Tcm) Lymphocytes are a fundamental component of the host immune cells are derived from CX3CR1− effector T cells and primarily response to challenge. Different classes of the lymphocyte circulate between the blood and secondary lymphoid organs. response are best defined by the type of effector programs Resident memory T (Trm) cells, although also derived from carried out by CD8+ or CD4+ T cells. CD8+ T cells are cytotoxic CX3CR1− effector T cells, enter peripheral tissues where they are lymphocytes that mediate a type 1 immune response to maintained locally by self-renewal and do not recirculate.
    [Show full text]
  • Module 3: Development of Immune Cells
    NPTEL – Biotechnology – Cellular and Molecular Immunology Module 3: Development of immune cells Lecture 15: Development of Lymphocytes (Part I) Pluripotent stem cells and fetal liver are considered as hematopoietic stem cells in the body which give rise to lineages of blood cells. Hematopoietic stem cells also differentiate into B cells, T cells, and antigen presenting cells following maturation. The maturation of B cells mostly occurs in the fetal liver before birth and in the bone marrow after birth. The T cells form in the liver before birth and complete maturation in thymus after birth. The most common form of T cells i.e αβ T cells develop in the bone marrow while less common form γδ T cells develop in neonatal liver. The differentiation of B and T lymphocytes from precursor stem cells largely depends on the signals induced by the surface receptors present over the hematopoietic stem cells which induce different transcriptional factors involved in its maturation. 15.1 Differentiation of B and T lymphocytes from progenitor cells 15.1.1 B cells differentiation Pluripotent hematopoietic stem cells differentiate into B cells under the influence of transcription factors E2A, EBF, and Pax5. These transcription factor works synergistically to induce the transcription of specific genes and their recombination responsible for the development of B lymphocytes. Pluripotent hematopoietic stem cells are differentiated into Pro-B cells which give rise to follicle B cells, marginal B cells, and B-1 B cells. 15.1.2 T cell differentiation Pluripotent hematopoietic stem cells first give rise to common lymphoid progenitor cells. The common lymphoid progenitor cells can either give rise to natural killer cells or Pro-T cells under the influence of different transcriptional factors.
    [Show full text]
  • CD8 Naive T Cell Counts Decrease Progressively in HIV-Infected Adults
    CD8 naive T cell counts decrease progressively in HIV-infected adults. M Roederer, … , L A Herzenberg, L A Herzenberg J Clin Invest. 1995;95(5):2061-2066. https://doi.org/10.1172/JCI117892. Research Article We show here that CD8 naive T cells are depleted during the asymptomatic stage of HIV infection. Although overall CD8 T cell numbers are increased during this stage, the naive CD8 T cells are progressively lost and fall in parallel with overall CD4 T cell counts. In addition, we show that naive CD4 T cells are preferentially lost as total CD4 cell counts fall. These findings, presented here for adults, and in the accompanying study for children, represent the first demonstration that HIV disease involves the loss of both CD4 T cells and CD8 T cells. Furthermore, they provide a new insight into the mechanisms underlying the immunodeficiency of HIV-infected individuals, since naive T cells are required for all new T cell-mediated immune responses. Studies presented here also show that the well-known increase in total CD8 counts in most HIV-infected individuals is primarily due to an expansion of memory cells. Thus, memory CD8 T cells comprise over 80% of the T cells in PBMC from individuals with < 200 CD4/microliter, whereas they comprise roughly 15% in uninfected individuals. Since the naive and memory subsets have very different functional activities, this altered naive/memory T cell representation has significant consequences for the interpretation of data from in vitro functional studies. Find the latest version: https://jci.me/117892/pdf CD8 Naive T Cell Counts Decrease Progressively in HIV-infected Adults Mario Roederer, J.
    [Show full text]
  • Immunology 101
    Immunology 101 Justin Kline, M.D. Assistant Professor of Medicine Section of Hematology/Oncology Committee on Immunology University of Chicago Medicine Disclosures • I served as a consultant on Advisory Boards for Merck and Seattle Genetics. • I will discuss non-FDA-approved therapies for cancer 2 Outline • Innate and adaptive immune systems – brief intro • How immune responses against cancer are generated • Cancer antigens in the era of cancer exome sequencing • Dendritic cells • T cells • Cancer immune evasion • Cancer immunotherapies – brief intro 3 The immune system • Evolved to provide protection against invasive pathogens • Consists of a variety of cells and proteins whose purpose is to generate immune responses against micro-organisms • The immune system is “educated” to attack foreign invaders, but at the same time, leave healthy, self-tissues unharmed • The immune system can sometimes recognize and kill cancer cells • 2 main branches • Innate immune system – Initial responders • Adaptive immune system – Tailored attack 4 The immune system – a division of labor Innate immune system • Initial recognition of non-self (i.e. infection, cancer) • Comprised of cells (granulocytes, monocytes, dendritic cells and NK cells) and proteins (complement) • Recognizes non-self via receptors that “see” microbial structures (cell wall components, DNA, RNA) • Pattern recognition receptors (PRRs) • Necessary for priming adaptive immune responses 5 The immune system – a division of labor Adaptive immune system • Provides nearly unlimited diversity of receptors to protect the host from infection • B cells and T cells • Have unique receptors generated during development • B cells produce antibodies which help fight infection • T cells patrol for infected or cancerous cells • Recognize “foreign” or abnormal proteins on the cell surface • 100,000,000 unique T cells are present in all of us • Retains “memory” against infections and in some cases, cancer.
    [Show full text]
  • The Anatomy of T-Cell Activation and Tolerance Anna Mondino*T, Alexander Khoruts*, and Marc K
    Proc. Natl. Acad. Sci. USA Vol. 93, pp. 2245-2252, March 1996 Review The anatomy of T-cell activation and tolerance Anna Mondino*t, Alexander Khoruts*, and Marc K. Jenkins Department of Microbiology and the Center for Immunology, University of Minnesota Medical School, 420 Delaware Street S.E, Minneapolis, MN 55455 ABSTRACT The mammalian im- In recent years, it has become clear that TCR is specific for a self peptide-class I mune system must specifically recognize a full understanding of immune tolerance MHC complex) T cell that will exit the and eliminate foreign invaders but refrain cannot be achieved with reductionist in thymus and seed the secondary lymphoid from damaging the host. This task is vitro approaches that separate the individ- tissues (3, 4). In contrast, cortical CD4+ accomplished in part by the production of ual lymphocyte from its in vivo environ- CD8+ thymocytes that express TCRs that a large number of T lymphocytes, each ment. The in vivo immune response is a have no avidity for self peptide-MHC bearing a different antigen receptor to well-organized process that involves mul- complexes do not survive and die by an match the enormous variety of antigens tiple interactions of lymphocytes with each apoptotic mechanism. Cortical epithelial present in the microbial world. However, other, with bone-marrow-derived antigen- cells are essential for the process of pos- because antigen receptor diversity is gen- presenting cells (APCs), as well as with itive selection because they display the self erated by a random mechanism, the im- nonlymphoid cells and their products. The peptide-MHC complexes that are recog- mune system must tolerate the function of anatomic features that are designed to op- nized by CD4+ CD8+ thymocytes and also T lymphocytes that by chance express a timize immune tolerance toward innocuous provide essential differentiation factors self-reactive antigen receptor.
    [Show full text]
  • Vaccine Immunology Claire-Anne Siegrist
    2 Vaccine Immunology Claire-Anne Siegrist To generate vaccine-mediated protection is a complex chal- non–antigen-specifc responses possibly leading to allergy, lenge. Currently available vaccines have largely been devel- autoimmunity, or even premature death—are being raised. oped empirically, with little or no understanding of how they Certain “off-targets effects” of vaccines have also been recog- activate the immune system. Their early protective effcacy is nized and call for studies to quantify their impact and identify primarily conferred by the induction of antigen-specifc anti- the mechanisms at play. The objective of this chapter is to bodies (Box 2.1). However, there is more to antibody- extract from the complex and rapidly evolving feld of immu- mediated protection than the peak of vaccine-induced nology the main concepts that are useful to better address antibody titers. The quality of such antibodies (e.g., their these important questions. avidity, specifcity, or neutralizing capacity) has been identi- fed as a determining factor in effcacy. Long-term protection HOW DO VACCINES MEDIATE PROTECTION? requires the persistence of vaccine antibodies above protective thresholds and/or the maintenance of immune memory cells Vaccines protect by inducing effector mechanisms (cells or capable of rapid and effective reactivation with subsequent molecules) capable of rapidly controlling replicating patho- microbial exposure. The determinants of immune memory gens or inactivating their toxic components. Vaccine-induced induction, as well as the relative contribution of persisting immune effectors (Table 2.1) are essentially antibodies— antibodies and of immune memory to protection against spe- produced by B lymphocytes—capable of binding specifcally cifc diseases, are essential parameters of long-term vaccine to a toxin or a pathogen.2 Other potential effectors are cyto- effcacy.
    [Show full text]
  • Blocking IL-25 Signalling Protects Against Gut Inflammation in a Type-2
    J Gastroenterol (2012) 47:1198–1211 DOI 10.1007/s00535-012-0591-2 ORIGINAL ARTICLE—ALIMENTARY TRACT Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13 Ana Camelo • Jillian L. Barlow • Lesley F. Drynan • Daniel R. Neill • Sarah J. Ballantyne • See Heng Wong • Richard Pannell • Wei Gao • Keely Wrigley • Justin Sprenkle • Andrew N. J. McKenzie Received: 18 November 2011 / Accepted: 22 March 2012 / Published online: 27 April 2012 Ó The Author(s) 2012. This article is published with open access at Springerlink.com Abstract infiltrates were assessed for mucosal inflammation and Background Interleukin-25 (IL-25) is a potent activator cultured in vitro to determine cytokine production. of type-2 immune responses. Mucosal inflammation in Results We found that in oxazolone colitis IL-25 pro- ulcerative colitis is driven by type-2 cytokines. We have duction derives from intestinal epithelial cells and that previously shown that a neutralizing anti-IL-25 antibody IL-17BR? IL-13-producing natural killer T (NKT) cells abrogated airways hyperreactivity in an experimental and nuocytes drive the intestinal inflammation. Blocking model of lung allergy. Therefore, we asked whether IL-25 signalling considerably improved the clinical aspects blocking IL-25 via neutralizing antibodies against the of the disease, including weight loss and colon ulceration, ligand or its receptor IL-17BR could protect against and resulted in fewer nuocytes and NKT cells infiltrating inflammation in an oxazolone-induced mouse model of the mucosa. The improved pathology correlated with a colitis. decrease in IL-13 production by lamina propria cells, a Methods Neutralizing antibodies to IL-25 or IL-17BR decrease in the production of other type-2 cytokines by were administered to mice with oxazolone-induced colitis, MLN cells, and a decrease in blood eosinophilia and IgE.
    [Show full text]
  • Naive and Memory T Cells Induce Different Types of Graft-Versus-Host Disease1
    The Journal of Immunology Naive and Memory T Cells Induce Different Types of Graft-versus-Host Disease1 Suparna Dutt,* Diane Tseng,* Joerg Ermann,* Tracy I. George,† Yin Ping Liu,* Corrine R. Davis,‡ C. Garrison Fathman,* and Samuel Strober2* The goal of this study was to compare the ability of donor naive and alloantigen-primed effector memory T cells to induce graft-vs-host disease after bone marrow transplantation in MHC-mismatched irradiated host mice. Purified CD4؉ naive CD62LhighCD44low) T cells and CD4؉ effector memory (CD62LlowCD44high) T cells obtained from unprimed donors and donors) primed to host alloantigens, respectively, were injected into host mice, and the rapidity, severity, and pattern of tissue injury of graft-vs-host disease was assessed. Unexpectedly, the naive T cells induced a more acute and severe colitis than the primed memory cells. Whereas the naive T cells expressing CD62L and CCR7 lymph node homing receptors vigorously expanded in mesenteric lymph nodes and colon by day 6 after transplantation, the primed memory T cells without these receptors had 20- to 100-fold lower accumulation at this early time point. These differences were reflected in the significantly more rapid decline in survival and weight loss induced by naive T cells. The primed memory T cells had a greater capacity to induce chronic colitis and liver injury and secrete IL-2 and IFN-␥ in response to alloantigenic stimulation compared with memory T cells from unprimed donors. Never- theless, the expected increase in potency as compared with naive T cells was not observed due to differences in the pattern and kinetics of tissue injury.
    [Show full text]
  • Resting B Lymphocytes As APC for Naive T Lymphocytes: Dependence on CD40 Ligand/CD401
    Resting B Lymphocytes as APC for Naive T Lymphocytes: Dependence on CD40 Ligand/CD401 Dean E. Evans,2 Michael W. Munks, Jeffrey M. Purkerson,3 and David C. Parker4 Although resting B cells as APC are tolerogenic for naive T cells in vivo, we show here that they can provide all the costimulatory signals necessary for naive T cell proliferation in vivo and in vitro. In the absence of an activating signal through the B cell Ag receptor, T cell proliferation after Ag recognition on resting B cells depends on CD40 expression on the B cells, implying that naive T cells use the membrane-bound cytokine, CD40 ligand (CD154), to induce the costimulatory signals that they need. Induction of B7-1 (CD80) and increased or sustained expression of CD44H, ICAM-1 (CD54), and B7-2 (CD86) are dependent on the interaction of CD40 ligand with CD40. Transient expression (12 h) of B7-2 is T cell- and peptide Ag-dependent, but CD40-independent. Only sustained (>24 h) expression of B7-2 and perhaps increased expression of ICAM-1 could be shown to be functionally important in this system. T cells cultured with CD40-deficient B cells and peptide remain about as responsive as fresh naive cells upon secondary culture with whole splenic APC. Therefore, B cells, and perhaps other APC, may be tolerogenic not because they fail to provide sufficient costimulation for T cell proliferation, but because they are deficient in some later functions necessary for a productive T cell response. The Journal of Immunology, 2000, 164: 688–697. Downloaded from he outcome of the interaction between an Ag-specific B A key regulator of Ag-specific T/B cell interactions is CD40 cell and an Ag-specific T cell can be tolerance or immu- ligand (CD40L;5 CD154), the membrane-bound ligand for CD40 T nity, depending on the state of activation of the T cell and and the major mediator of contact-dependent help for B cell pro- the B cell, although the rules and the molecular interactions that liferation and differentiation in the Ab response (19, 20).
    [Show full text]